CN106857878A - Yoghurt without sugar powder - Google Patents
Yoghurt without sugar powder Download PDFInfo
- Publication number
- CN106857878A CN106857878A CN201510917563.1A CN201510917563A CN106857878A CN 106857878 A CN106857878 A CN 106857878A CN 201510917563 A CN201510917563 A CN 201510917563A CN 106857878 A CN106857878 A CN 106857878A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- sugar
- yoghurt
- coacetylase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 46
- 235000013618 yogurt Nutrition 0.000 title claims abstract description 34
- 235000000346 sugar Nutrition 0.000 title claims abstract description 31
- 235000013336 milk Nutrition 0.000 claims abstract description 14
- 239000008267 milk Substances 0.000 claims abstract description 14
- 210000004080 milk Anatomy 0.000 claims abstract description 14
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 11
- 239000003765 sweetening agent Substances 0.000 claims abstract description 11
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 8
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 6
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 6
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 6
- 239000005862 Whey Substances 0.000 claims abstract description 6
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 6
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 6
- 239000000811 xylitol Substances 0.000 claims abstract description 6
- 235000010447 xylitol Nutrition 0.000 claims abstract description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 6
- 229960002675 xylitol Drugs 0.000 claims abstract description 6
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 15
- 235000014655 lactic acid Nutrition 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 8
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical group [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 3
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 3
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 3
- 229960004998 acesulfame potassium Drugs 0.000 claims description 3
- 239000000619 acesulfame-K Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 108010011485 Aspartame Proteins 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 229930003270 Vitamin B Natural products 0.000 abstract description 5
- 235000019156 vitamin B Nutrition 0.000 abstract description 5
- 239000011720 vitamin B Substances 0.000 abstract description 5
- 206010010774 Constipation Diseases 0.000 abstract description 4
- 235000013365 dairy product Nutrition 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 230000008855 peristalsis Effects 0.000 abstract description 3
- 208000008589 Obesity Diseases 0.000 abstract description 2
- 210000000577 adipose tissue Anatomy 0.000 abstract description 2
- 150000001720 carbohydrates Chemical class 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 235000020824 obesity Nutrition 0.000 abstract description 2
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000004376 Sucralose Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
- A23C21/026—Whey; Whey preparations containing, or treated with, microorganisms or enzymes containing, or treated only with, lactic acid producing bacteria, bifidobacteria or propionic acid bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Dairy Products (AREA)
Abstract
The present invention relates to technical field of dairy products, particularly a kind of yoghurt without sugar powder.The mass parts of the yoghurt without sugar powder each component are：Milk powder 90-100 parts, desalted whey powder 10-20 parts, albumen powder 1-20 parts, soybean lecithin 1-20 parts, oligopeptides 3-10 parts, non-sugar sweetener 0.01-0.05 parts, xylitol 5-10 parts, FOS 1-3 parts, 0.01-2 parts, soluble dietary fiber 3-8 parts, vitamin B 0.001-0.003 parts, coacetylase 0.00001-0.0001 parts, hydroxymalonic acid 0.00001-0.0001 parts of Bacillus acidi lactici powder.Yoghurt without sugar powder of the invention, traditional sugar sweetener is replaced with non-sugar sweetener, on the premise of mouthfeel is ensured, disclosure satisfy that the demand of special population；Soluble dietary fiber, can stimulate intestines peristalsis, can Constipation, angiocardiopathy and obesity；It is fat that hydroxymalonic acid can suppress saccharide converted in human body, prevents body fat from piling up, and coacetylase can promote fat metabolism.
Description
Technical field
The present invention relates to technical field of dairy products, particularly a kind of yoghurt without sugar powder.
Background technology
Yoghourt be with milk as raw material, by after pasteurize again to milk in add beneficial bacterium (leavening), it is fermented after, then
A kind of filling milk product of cooling.Sugared, protein has 20% or so to be hydrolyzed into for small is divided during the fermentation process of Yoghourt makes milk
Sub (such as galactolipin and lactic acid, small peptide chain and amino acid), fat content is usually 3%~5% in milk.After fermented, breast
In aliphatic acid than raw material milk increase by 2 times, these changes make Yoghourt more easy to digest and absorb, and the utilization rate of various nutrients is obtained
To improve.Yoghourt is formed by plain chocolate fermentation, in addition to the whole nutritional ingredients for remaining fresh milk, lactic acid bacteria during the fermentation
Multivitamin, such as VB1, VB2, VB6, VB12 necessary to human nutrition can be produced with one.
Yoghourt also contains lactic acid bacteria in addition to nutritious, so with health role.1. the gut flora ecological balance is safeguarded,
Biological barrier is formed, suppresses invasion of the harmful bacteria to enteron aisle.2. intestines peristalsis and bacterium are promoted by producing substantial amounts of SCFA
Body raised growth changes osmotic pressure and prevents constipation.3. Yoghourt contains various enzymes, promotes to digest and assimilate.4. by suppressing saprophytic bacteria
In the growth of enteron aisle, it is suppressed that the toxin produced by corruption, make liver and brain from the harm of these toxin, prevent aging.
5. by suppressing the growth of saprophytic bacteria and some bacterium in enteron aisle.So as to also inhibits the carcinogen produced by these bacterium, reach anti-
The purpose of cancer.6. immune function of human body is improved, and lactic acid bacteria can produce the material of some enhancing immunologic functions, can improve human body
It is immune, prevent disease.Yoghourt containing a large amount of active bacterias can help improve lactose intolerance, constipation, diarrhoea, enteritis, pylorus
The illnesss such as pylori (Hp) infection.7 reduce blood pressure：HSPH of Harvard University epidemiological study person Ai Erwaluoa
Good doctor Suo introduces, and research finds, in those daily 2~3 parts or more the people of Yoghourt of drink, the initiation potential ratio of hypertension
Those people not drunk reduce 50%.
It with dairy products is raw material through lactobacillus bulgaricus that traditional Yoghourt fermentation technology is, streptococcus thermophilus, Lactobacillus casei,
The various lactobacillus cooperative fermentation such as Bifidobacterium is made, and in order to improve mouthfeel, sucrose is generally additionally added, for traditional yogurt
The nutritional ingredient of product is essentially from dairy products.Traditional yogurt need to the preservation at 2 DEG C~6 DEG C, under normal circumstances, biodiasmin
Preserved in 0 DEG C~4 DEG C of environment, at this moment lactic acid bacteria is in " rest period ", and thalline is active, but reproduction speed is slower；With
The rising lactic acid bacteria of environment temperature and can quickly breed, quick death, its nutritive value can also decrease.Traditional yogurt is guaranteed the quality
Phase is shorter, generally two weeks or so.
At present, most of the fermented yoghourt in market is, with fresh milk as primary raw material, to be formed using directly putting type fermented strain fermentation.
But, the shelf-life of these Yoghourts is very short, in order to improve mouthfeel, is generally additionally added the sugar sweeteners such as sucrose, special to consumer
It is not that the crowd of the crowd and overweight that are not suitable for table sugar makes troubles.
The content of the invention
It is an object of the invention to the drawbacks described above for overcoming prior art to exist, there is provided a kind of yoghurt without sugar powder, ensureing mouthfeel
Under the premise of, disclosure satisfy that the demand of special population.
The present invention is realized using following technical scheme：
A kind of yoghurt without sugar powder, the mass parts of the yoghurt without sugar powder each component are：Milk powder 90-100 parts, desalted whey powder 10-20
Part, albumen powder 1-20 parts, soybean lecithin 1-20 parts, oligopeptides 3-10 parts, non-sugar sweetener 0.01-0.05 parts, xylitol
5-10 parts, FOS 1-3 parts, 0.01-2 parts of Bacillus acidi lactici powder, soluble dietary fiber 3-8 parts, vitamin B 0.001-0.003
Part, coacetylase 0.00001-0.0001 parts, hydroxymalonic acid 0.00001-0.0001 parts.
The non-sugar sweetener be acesulfame potassium, Sucralose, Aspartame in one or more.
The lactic acid bacteria powder is Bulgarian Bifidobacterium or Lactobacillus delbrueckii.
The beneficial effects of the invention are as follows：Yoghurt without sugar powder of the invention, traditional sugar sweetener is replaced with non-sugar sweetener,
On the premise of mouthfeel is ensured, the demand of special population is disclosure satisfy that；Soluble dietary fiber, can stimulate intestines peristalsis, can be pre-
Avoid constipation, angiocardiopathy and obesity；It is fat that hydroxymalonic acid can suppress saccharide converted in human body, prevents body fat from piling up,
Coacetylase can promote fat metabolism.
Specific embodiment
With reference to embodiment, the present invention will be further described.
Embodiment 1
A kind of yoghurt without sugar powder, the mass parts of the yoghurt without sugar powder each component are：90 parts of milk powder, 10 parts of desalted whey powder,
1 part of albumen powder, 1 part of soybean lecithin, 3 parts of oligopeptides, 0.01 part of acesulfame potassium, 5 parts of xylitol, 1 part of FOS, guarantor add
0.01 part of Leah Bifidobacterium powder, 3 parts of soluble dietary fiber, 0.001 part of vitamin B, 0.00001 part of coacetylase, propyl alcohol
0.00001 part of diacid.
Embodiment 2
A kind of yoghurt without sugar powder, the mass parts of the yoghurt without sugar powder each component are：100 parts of milk powder, 20 parts of desalted whey powder,
20 parts of albumen powder, 20 parts of soybean lecithin, 10 parts of oligopeptides, 0.05 part of Sucralose, 10 parts of xylitol, 3 parts of FOS,
2 parts of Lactobacillus delbrueckii powder, 8 parts of soluble dietary fiber, 0.003 part of vitamin B, 0.0001 part of coacetylase, hydroxymalonic acid
0.0001 part.
Embodiment 3
A kind of yoghurt without sugar powder, the mass parts of the yoghurt without sugar powder each component are：95 parts of milk powder, 15 parts of desalted whey powder,
15 parts of albumen powder, 15 parts of soybean lecithin, 7 parts of oligopeptides, 0.03 part of non-sugar sweetener, 7 parts of xylitol, FOS 2
Part, 1 part of Bacillus acidi lactici powder, 5 parts of soluble dietary fiber, 0.002 part of vitamin B, 0.0005 part of coacetylase, propyl alcohol two
0.00005 part of acid.
Claims (3)
1. a kind of yoghurt without sugar powder, it is characterised in that the mass parts of the yoghurt without sugar powder each component are：Milk powder 90-100 parts,
Desalted whey powder 10-20 parts, albumen powder 1-20 parts, soybean lecithin 1-20 parts, oligopeptides 3-10 parts, non-sugar sweetener 0.01-0.05
Part, xylitol 5-10 part, FOS 1-3 parts, 0.01-2 parts of Bacillus acidi lactici powder, soluble dietary fiber 3-8 parts, tie up
Raw B0.001-0.003 parts, coacetylase 0.00001-0.0001 parts, hydroxymalonic acid 0.00001-0.0001 parts of element.
2. yoghurt without sugar powder according to claim 1, it is characterised in that the non-sugar sweetener is acesulfame potassium, trichlorine
One or more in sucrose, Aspartame.
3. yoghurt without sugar powder according to claim 1, it is characterised in that the lactic acid bacteria powder is Bulgarian Bifidobacterium
Or Lactobacillus delbrueckii.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510917563.1A CN106857878A (en) | 2015-12-11 | 2015-12-11 | Yoghurt without sugar powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510917563.1A CN106857878A (en) | 2015-12-11 | 2015-12-11 | Yoghurt without sugar powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106857878A true CN106857878A (en) | 2017-06-20 |
Family
ID=59177204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510917563.1A Pending CN106857878A (en) | 2015-12-11 | 2015-12-11 | Yoghurt without sugar powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106857878A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111587922A (en) * | 2020-05-28 | 2020-08-28 | 武汉微康益生菌研究院有限公司 | Yoghourt powder and preparation method thereof |
| CN112244094A (en) * | 2020-10-19 | 2021-01-22 | 湖南欧比佳营养食品有限公司 | Functional yoghurt powder for middle-aged and elderly people and preparation method thereof |
| CN114081072A (en) * | 2021-10-13 | 2022-02-25 | 济南斯伯特生物科技有限公司 | High-protein sugar-free low-fat solidified yoghurt powder suitable for diabetes weight-losing people |
-
2015
- 2015-12-11 CN CN201510917563.1A patent/CN106857878A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111587922A (en) * | 2020-05-28 | 2020-08-28 | 武汉微康益生菌研究院有限公司 | Yoghourt powder and preparation method thereof |
| CN112244094A (en) * | 2020-10-19 | 2021-01-22 | 湖南欧比佳营养食品有限公司 | Functional yoghurt powder for middle-aged and elderly people and preparation method thereof |
| CN114081072A (en) * | 2021-10-13 | 2022-02-25 | 济南斯伯特生物科技有限公司 | High-protein sugar-free low-fat solidified yoghurt powder suitable for diabetes weight-losing people |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chandan et al. | Yogurt: Historical background, health benefits, and global trade | |
| Shah | Yogurt in health and disease prevention | |
| Vijaya Kumar et al. | Trends in dairy and non-dairy probiotic products-a review | |
| Shah | Health benefits of yogurt and fermented milks | |
| Weerathilake et al. | The evolution, processing, varieties and health benefits of yogurt | |
| Shiby et al. | Fermented milks and milk products as functional foods—A review | |
| Tamime et al. | Production and maintenance of viability of probiotic microorganisms in dairy products | |
| Puniya | Fermented milk and dairy products | |
| Li et al. | Health implication of lactose intolerance and updates on its dietary management | |
| Hati et al. | Technological advancement of functional fermented dairy beverages | |
| KR102423025B1 (en) | Food composition and health functional food containing Lactobacillus rhamnosus IDCC 3201 with proteolytic ability | |
| CN106857825A (en) | Improve the sour milk powder of sleep quality | |
| CN106857824A (en) | Shield stomach sour milk powder | |
| Pimentel et al. | Brazilian yogurt-like products | |
| KR102523775B1 (en) | Food composition and health functional food containing Lactobacillus plantarum IDCC 3501 with proteolytic ability | |
| CN106857878A (en) | Yoghurt without sugar powder | |
| CN106857821A (en) | Diet yogurt powder | |
| CN106857842A (en) | Antialcoholic sour milk powder | |
| CN109430394A (en) | A kind of low alcohol sour milk beverage and preparation method thereof | |
| CN111109360A (en) | Miracle fruit-containing yoghourt and preparation method thereof | |
| CN106857822A (en) | Voluntarily fermented yoghourt powder | |
| WO2021200900A1 (en) | Fermentation composition, method for producing fermentation composition, and viability improving agent | |
| KR102538090B1 (en) | Food composition and health functional food containing Lactobacillus casei IDCC 3451 with proteolytic ability | |
| CN109475583B (en) | Composition for inhibiting erythema, method for using and method for producing the same, method for inhibiting erythema, and lactic acid bacterium product | |
| KR20180038184A (en) | Compositions of dietary supplements for improvement of hyperlipidemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170620 |
|
| WD01 | Invention patent application deemed withdrawn after publication |